The Role of Copper and Zinc Toxicity in Innate Immune Defense against Bacterial Pathogens. by Djoko, Karrera Y et al.
The Role of Copper and Zinc
Toxicity in Innate Immune
Defense against Bacterial
Pathogens*
Published, JBC Papers in Press, June 8, 2015, DOI 10.1074/jbc.R115.647099
Karrera Y. Djoko1, Cheryl-lynn Y. Ong1, Mark J. Walker,
and Alastair G. McEwan2
From the School of Chemistry andMolecular Biosciences and Australian
Infectious Diseases Research Centre, The University of Queensland,
St. Lucia, Queensland 4072, Australia
Zinc (Zn) and copper (Cu) are essential for optimal innate
immune function, and nutritional deficiency in either metal
leads to increased susceptibility to bacterial infection. Recently,
the decreased survival of bacterial pathogens with impaired Cu
and/or Zn detoxification systems in phagocytes and animal
models of infection has been reported. Consequently, a model
has emerged in which the host utilizes Cu and/or Zn intoxica-
tion to reduce the intracellular survival of pathogens. This
review describes and assesses the potential role for Cu and Zn
intoxication in innate immune function and their direct bacte-
ricidal function.
Six first row d-block metal ions, manganese (Mn), iron (Fe),
cobalt (Co), nickel (Ni), copper (Cu), and zinc (Zn), are essential
micronutrients in living organisms. Investigations and discus-
sions of the roles of these trace metals in biology often relate to
their acquisition, storage, and incorporation into enzymes.
However, conditions where these metal ions are present in
excess or are found in the wrong location, resulting in toxicity,
have also been described. Thus, there are also systems that
sequester, export, and detoxify excess trace metal ions. Today,
the concept of trace metal homeostasis, in which various cellu-
lar actions maintain the fine balance between nutrition and
toxicity, is well developed.
Recently, the concept of “nutritional immunity” has emerged
in the context of host defense against pathogens. This envisages
a role for mechanisms that protect the host from invading
pathogens by restricting their ability to acquire key transition
metal ions.One example involves lipocalin, which binds sidero-
phores and thereby prevents Fe acquisition by bacterial patho-
gens (1). Another is calprotectin, which restricts acquisition of
Zn orMn (2). However, what if the host was able to harness the
toxic properties of transition metal ions and use them as bacte-
ricides? This review explores the evidence for an antimicrobial
role for Cu and Zn in the host defense against bacterial
pathogens.
The Importance of Cu and Zn for Innate Immune
Function
The innate immune system is a collection of cells and pro-
teins that are functionally diverse and that defend against inva-
sion by foreign organisms. At sites of infection, epithelial cells
act as the first and highly effective layer of barrier, but if they are
breached, a rapid influx of phagocytes such as neutrophils and
macrophages will assist in curbing the initial progress of infec-
tion. Engulfment of pathogens by these phagocytes helps acti-
vate adaptive immunity, which leads to a permanent resolution
of the infection.
The link between Cu and innate immune function has been
recognized for decades. Early literature recorded that mild Cu
deficiency in humans and animals was often characterized by
neutropenia (3, 4). This condition was associated partly with a
decrease in the number of circulating neutrophils, and thus a
role for Cu in leukocyte differentiation, maturation, and prolif-
eration has been proposed (5). Of interest in this review are the
observations that Cu deficiency also led to impaired neutrophil
function. Neutrophils isolated from hypocupremic subjects
displayed reduced phagocytic capacity and/or diminished bac-
tericidal activity, but these actions were restored readily upon
dietary supplementation with Cu (6, 7). Cu deficiency had sim-
ilar effects on macrophage function, and macrophages isolated
fromCu-starved rats had a reducedCu content and a decreased
antimicrobial activity (8).
It thus followed that dietarymanipulations of Cu levels influ-
enced the susceptibility of animal hosts to bacterial infections.
Cu-deprived diets typically sensitized the animal to infection,
prolonged the duration of infection, and increased mortality
rates (9–11). These phenotypes were suppressed by increasing
Cu intake (12, 13). This apparent Cu requirement for optimal
innate immune function has been verified recently using cell
culture models of mouse macrophages. Pretreatment with
added Cu boosted macrophage antibacterial activity and
enhanced intracellular killing of Escherichia coli (K12) (14).
Conversely, Cu starvation as induced by the non-permeable
Cu(I) chelator bathocuproine disulfonate led to a decline in
bactericidal function and an increase in the intracellular sur-
vival of the pathogen Salmonella enterica serovar Typhimu-
rium (15). The effect was again reversible by the readdition of
Cu into the culture medium.
Like Cu, appropriate levels of Zn are required for the proper
functioning of the immune system. The importance of Zn in
immunity is notably illustrated by the high occurrences of
infectious diseases in developing nations due to Zn-poor diets
(16–18). Zn is essential for the normal development and activ-
ity of cells involved in both innate and acquired immunity.
Recently, there have been reports that Zn might function as a
signaling molecule (19, 20). Of relevance to this review, studies
of Zn-deficient animals and human conditions of Zn deficiency
have shown that, although there was no loss of total neutrophil
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numbers, there was a decrease in their chemotactic response
(21–23). Zn deficiency also led to a reduced chemotactic
response ofmonocytes andmacrophages, resulting in impaired
phagocytosis and intracellular killing of pathogens (24–27).
These effects were readily reversible by Zn supplementation.
Antibacterial Effects of Cu and Zn
The precise roles for Cu in innate immune function remain
to be fully explored, but the current hypothesis postulates that
Cu ions may be harnessed directly by phagocytes as an antibac-
terial agent, and this model has gained significant traction in
recent years (28–30). The antibacterial effects of excess Cu ions
are quite well understood. Within the reducing bacterial cyto-
plasm, Cu exists exclusively as Cu(I), and its level is buffered by
Cu(I)-specific, high-affinity sites (31). However, the Cu(I)/
Cu(II) redox couple remains biologically accessible. Thus,
excess or “unbuffered” (weakly bound) Cu(I) ions are poised to
catalyze gratuitous electron transfer. In the context of host-
pathogen interactions, this action of Cu(I) as a redox catalyst is
considered to be of critical relevance. The activities of the host
NADPH oxidase during the initial respiratory burst and induc-
ible NOS during the late phase of infection generate a potent
mixture of antimicrobials, namely O2. and NO, respectively
(32). If Cu(I) is also mobilized to this environment, it would
potentiate the redox cycling of these reactive oxygen and nitro-
gen species (33, 34). This cycling may produce additional
redox-active species and concomitantly deplete crucial bacte-
rial antioxidants such as thiols, causing severe oxidative or
nitrosative stress and ultimately bacterial death (35, 36).
Excess Cu(I) may also exert a bacteriotoxic effect via alterna-
tive mechanisms that are redox-independent. Cu(I) may out-
compete other d-block metal micronutrients from their bind-
ing sites in metalloproteins, especially those that contain soft
thiolate ligands, as the affinities of such sites to transition met-
als tend to follow the Irving-Williams series. One well charac-
terized example is the displacement of Fe(II) from solvent-ex-
posed Fe-S clusters by Cu(I) (37–41). The consequence is a
systemic disruption of bacterial metabolic pathways that rely
on the activity of Fe-S cluster enzymes. This may have down-
stream repercussions on intracellular survival in the host. For
instance, inhibition of coproporphyrinogen(III) oxidase in the
pathway for heme biosynthesis in Neisseria gonorrhoeae led to
defects in heme-dependent defenses against H2O2 and NO
(33, 40).
In contrast to Cu, Zn is not usually regarded as having the
same level of toxicity. Zn is present in up to 10% of proteins in
the human proteome, and computational analysis predicted
that 30% of these 3000 Zn-containing proteins are crucial
cellular enzymes, such as hydrolases, ligases, transferases, oxi-
doreductases, and isomerases (42, 43). This suggests that Zn is
well tolerated or, more correctly, that the cell has mechanisms
to control homeostasis of this metal ion.
Like Cu, Zn is regulated tightly within cells by high-affinity
sites, and intracellular “free” Zn is kept well below the pM range
(44). However, like Cu, Zn lies at the top of the Irving-Williams
series, and there is evidence that Zn exerts an antimicrobial
effect by antagonizing the uptake of other key tracemetal nutri-
ents. In Streptococcus pneumoniae, excess Zn was shown to
prevent the uptake of Mn(II) by binding irreversibly to the
extracellular Mn(II) solute binding protein PsaA (45, 46). Con-
sequently, S. pneumoniae becomes hypersensitive to oxidative
stress (45, 46). Zn may also bind adventitiously to other sites
that do not normally contain ametal ion and thereby inhibit key
enzymes in cells (35, 47–49).Wehave addressed this in the case
of the human bacterial pathogen Streptococcus pyogenes and
shown that exposure to elevated Zn results in inhibition of gly-
colytic enzymes and phosphoglucomutase (50). The latter is a
key enzyme in the biosynthesis of capsule.
Evidence for a Direct Role of Cu and Zn in the Control of
Bacterial Infection
The Role of Bacterial Cu and Zn Detoxification Systems in
Virulence
The bulk of the evidence for a role of Cu as a host-derived
antibacterial has been inferred from phenotypic characteriza-
tion of bacterial mutants that are impaired in key functions
associated with Cu detoxification. These mutants typically dis-
play reduced virulence in animal andmacrophagemodel hosts,
but the tolerance determinant varies and notable exceptions do
exist (Table 1).
Bacterial Cu detoxification systems are diverse and are often
found in some degree of redundancy, as best exemplified by the
dual CueR/CusRS systems in E. coli (51), the CsoR/RicR regu-
lons inMycobacterium tuberculosis (52, 53), and the SctR/GolS
systems in S. Typhimurium (54). These redundancies may also
be a strategy to fine-tune the response to fluctuatingCu levels in
the environment. Other detoxification systems are consider-
ably more straightforward, such as the Cop regulon in S. pneu-
moniae (55) and the single-component CopA system inN. gon-
orrhoeae (33). Based on current understanding of these
systems, theminimumrequirement forCu tolerance appears to
be a membrane-bound, Cu(I)-effluxing ATPase that extrudes
Cu(I) ions from the cytoplasm, usually designated as CopA.
Inactivation of the copA gene invariably leads to trapping of Cu
in the cytoplasm. Predictably, this failure to remove cytoplas-
mic Cu renders copAmutants sensitive to in vitro killing by Cu
salts (33, 55, 56). copA usually operates under the control of
Cu(I)-sensing transcription factors, whichmay also activate the
expression of accessory genes that encode for cytoplasmic or
periplasmic Cu chaperones and periplasmic cuprous oxidases
(CueO),3 all of which are necessary for optimal Cu tolerance in
vitro (57, 58).
If Cu acts as a host bactericide, inactivation of copA should
suppress virulence of the invading pathogen. This was indeed
the case in several, but not all, medically significant pathogens.
The copA mutant strains of Pseudomonas aeruginosa (cueA)
(59) and S. pneumoniae (55, 60) were less invasive in murine
host models of systemic infection. The copA mutant strain of
N. gonorrhoeae also had impaired survival within cervical epi-
thelial cell host (33). By contrast, the copA mutants of Listeria
monocytogenes (61, 62), Vibrio cholerae (63), and S. Typhimu-
rium (56) displayed no loss of pathogenic fitness in animal or
macrophage infection models.
3 The abbreviations used are: CueO, cuprous oxidase; ZnT, zinc transporter.
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Here, it is important to recognize that some prokaryotes pos-
sess more than one Cu(I) efflux pump, and these may be able to
compensate for the loss of CopA. For S. Typhimurium, a phe-
notype for the copAmutant in terms of survival within macro-
phages was observed only upon simultaneous inactivation of
golT (56), which encodes for a second Cu(I)-exporting pump in
this bacterium. Nonetheless, virulence of the copA/golT double
mutant was maintained in a mouse model host (56). For
M. tuberculosis, inactivation of the copA homologue ctpV had
no clear effect onmycobacterial pathogenesis inmice or guinea
pigs (64), but disruption of an alternative Cu(I) export pump
encoded bymctBwas detrimental to survival (13). Likewise, for
L. monocytogenes, only the plasmid-borne ctpA gene but not
the chromosomal copA gene was essential for long-term colo-
nization ofmice (62).However, the behavior of the ctpAmutant
in isolated macrophages was indistinguishable from that of the
parent strain (62).
Although the above examples suggest that pathogenic suc-
cess depends on an efficient removal of excess Cu from the
bacterial cytoplasm, the importance of controlling Cu in the
bacterial envelope or periplasmmust not be overlooked.Muta-
tion of the cusFCBA operon was recently shown to suppress
colonization by uropathogenic E. coli in a mouse model of uri-
nary tract infection (12). The cus operon encodes for a second-
ary Cu(I) efflux system in E. coli that protects against periplas-
mic Cu toxicity under anaerobic conditions (51, 65). The effect
of copAmutation in this genetic background is not known, but
inactivation of copA in the laboratory strain K12 was shown to
impair its ability to colonize mouse macrophages (14). Simi-
larly, a cueO mutant strain of S. Typhimurium lacking the
periplasmic cuprous oxidase was attenuated inmouse liver and
spleen (57), although it showed no phenotype in isolated
macrophages. The results with cueO were different from those
generated with the copA/golT double mutant, which showed
reduced survival only in macrophages but not in mice (56). At
present, a rationale for this apparent discrepancy is not avail-
able, but it must be mentioned that inactivation of cueO in
E. coli (K12 and uropathogenic strain) caused pleiotropic
effects that were unrelated to Cu tolerance (66, 67).
To some extent, bacterial Zn detoxification systems appear
simpler when compared with those of Cu. They typically con-
sist of a transcriptional response regulator paired with the Zn
efflux transporter, although theremay be some redundancies in
these exporters. The best exemplified Zn export systems in the
literature are the ZntR/ZntA regulator/P-type ATPase Zn
efflux system in E. coli (68, 69) and the GczA (SczA)/CzcD reg-
ulator/cation diffusion facilitator system in S. pyogenes and
S. pneumoniae (70, 71).
In relation to infection, it has been established that Zn defi-
ciency in animal models promotes susceptibility to bacterial
pathogens such as L. monocytogenes (72) and M. tuberculosis
(73). Until recently, all evidence had pointed to Zn deprivation
as the key antimicrobial strategy in innate immune cells, and
reports of bacterial Zn export as a virulence determinant had
TABLE 1
Phenotypic characterization of bacterial mutants that are impaired in Cu detoxification (export)
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been limited (Table 2). In 2011, Botella et al. (74) demonstrated
that a mutant strain ofM. tuberculosis that lacks the Zn-efflux-
ing ATPase CtpC was attenuated in a human-derived macro-
phage model of infection. However, there was no observable
loss of virulence in mice (74). Similarly, a zntA deletion mutant
of E. coli also had reduced survival within humanmacrophages
when compared with the wild type strain (74). These results are
clearly consistent with the idea that, like Zn starvation, Zn
excessmay also play an antimicrobial role. Subsequently, it was
shown that inactivation of czcD, which encodes for the Zn-
specific cation diffusion facilitator in S. pyogenes, led to a
decreased survival in human neutrophils and a reduced viru-
lence in a mouse model of infection (71). Similarly, deletion of
cznABC, a broad-spectrumATP-binding cassette (ABC) trans-
port system that is thought to play a role in the export of Zn,
resulted in decreased virulence ofHelicobacter pylori in a gerbil
model of gastric infection (75).
Alterations in Host Cu and Zn Status in Response to Bacterial
Infection
Additional support for the involvement of Cu in the clear-
ance of intracellular pathogens is available from studies that
examine the host responses to bacterial infection. In response
to inflammation by S. Typhimurium or the proinflammatory
agent SalmonellaLPS, expression ofATP7A,which encodes for
the ATP-dependent Cu(I) transporter ATP7A, was elevated in
mousemacrophages (15). ATP7A is required for the biosynthe-
sis of cuproenzymes, and so it usually resides in the Golgi appa-
ratus. This expression of ATP7A was accompanied by robust
increases in the expression of CTR1 and CTR2, which encode
for transporters for the import of Cu(I) into the cytoplasm, and
CP, which encodes for ceruloplasmin (15).
These alterations in the expression of genes involved in Cu
metabolismmay signify a concerted boosting of Cu uptake into
the host cell. One hypothesis proposes that Cu is trafficked
specifically to phagosomes to enhance killing of intracellular
bacteria. Indeed, activation of mouse macrophages by IFN-
was shown to trigger partial trafficking of ATP7A to phago-
somal compartments (14). Consistent with this hypothesis,
RNAi silencing of ATP7A diminished the bactericidal activ-
ity of these macrophages against engulfed E. coli K12 (14).
However, direct detection of Cu levels within phagosomes,
whether before, during, or after infection, has not yet been
confirmed. Elemental analyses of mouse macrophages by
x-ray fluorescence detected an apparent increase in the
amounts of Cu in extracellular M. tuberculosis when com-
pared with those in internalized bacteria within mycobacte-
rium-containing phagosomes, but this difference was not
statistically significant (76). A separate imaging study of
mouse macrophages using the fluorescent sensor CS-1 also
showed that although Cu ions were mobilized to discrete
vesicles in response to inflammation by S. Typhimurium,
these Cu-rich vesicles did not co-localize with Salmonella-
containing vacuoles (15).
Nevertheless, there was activation of the copA promoter of S.
Typhimurium during interactions with mouse macrophages
(56). This requirement for CopA function certainly implies a
situation of Cu excess. However, it should be noted that the
copA promoter was activated only after 12–24 h after infection
(56). This timing coincides nicely with the expression of Cu
homeostasis genes in macrophages, which peaked at 14 h after
infection (15). This apparent elevation of Cu does not coincide
with the timing of the oxidative burst in macrophages. Instead,
it is temporally more coincident with the onset of nitric oxide
production.
Mammalian Zn homeostasis is highly complex. It can involve
10 ZnT (SLC30) family and 14 ZIP (SLC39) family transporters,
as well asmetal transcription factors (MTF-1/2) and Zn storage
proteins (77). Prior to the findings by Botella et al. (74), there
was an emphasis on Zn deprivation as the key antimicrobial
strategy in innate immune cells, based on inference from the
function of metallothionein and calprotectin. Recently, the use
of gene expression studies in conjunction with total metal
analysis and fluorescent microscopy has allowed better detec-
tion of Zn and its mobilization within innate immune cells.
Immunofluorescence microscopy of macrophages infected
withM. tuberculosis indicated that Zn was released from intra-
cellular stores (metallothionein) and trafficked into mycobac-
terial-containing phagosomes (74). Likewise, internalization of
S. pyogenes correlatedwith the release of Znwithin humanneu-
trophils (71).
This increase in Znwithin innate cells has also been observed
during fungal infections.Metal analysis demonstrated that total
Zn content was increased within activated macrophages
infected with the fungal pathogen Histoplasma capsulatum
(78). This was the result of increased Zn import via the ZIP2
importer, but the Zn ion was then distributed to intracellular
TABLE 2
Phenotypic characterization of bacterial mutants that are impaired in Zn detoxification (export)
Bacterium Strain
Export
determinant Host model (infection mode)
Phenotype relative to the wild
type strain Reference
E. coli BW25113 zntA Human macrophages Decreased intracellular survival [73]
EC958 Human neutrophils Decreased intracellular survival McEwan laboratory,
unpublished
H. pylori P149 cznABC Gerbil (oral-gastric) Decreased bacterial load in the
stomach
[74]
M. tuberculosis GC1237 ctpC Human macrophages Decreased intracellular survival [73]
Mice (intranasal) No difference in bacterial
burden in the lung; no
difference in survival
[73]
S. pyogenes 5448 czcD Human neutrophils Decreased survival [70]
Mice (subcutaneous) Decreased survival [70]
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organelles such as the Golgi apparatus via Zn transporters
ZnT4 and ZnT7 or bound to metallothionein (78).
By contrast, LPS binding to the TLR4 receptor does not trig-
ger Zn import into themacrophage. Instead, it rapidly increases
the expression of the ZIP8 importer located on the lysosomal
membrane (79, 80). However, this action also elevates the free
Zn levels in the cytosol, which can trigger the production of
inflammatory cytokines, resulting in T-cell proliferation (81,
82). Despite occurring through different mechanisms, both
bacterial and fungal infections result in increased freeZnwithin
innate immune cells. As prolonged inflammatory response can
be detrimental to the host, it must be regulated to minimize
tissue damage. Recently, this role of Zn as a signaling molecule
has been further defined by demonstrating that the elevated Zn
within monocytes and macrophages results in dampening of
the inflammatory response via a negative feedback loop (80).
The elevated cytosolic Zn within monocytes and macrophages
(imported via ZIP8) was shown to suppress NF-B signaling,
leading to decreased expression of cytokines such as IL-6 and
TNF-, which in turn leads to decreased inflammation (80).
Thus, it is clear that Zn is central to the control of the inflam-
matory response in response to infection.
Trafficking of Cu and Zn to Sites of Infections
The biodistribution of Cu in whole animals and humans has
been studied extensively following exogenous administration
of synthetic Cu salts and complexes, although not always coin-
cident with bacterial infection (83, 84). In most cases, the Cu
was trafficked to the liver and kidney, as would be expected
from our current understanding of mammalian Cu transport
and metabolism (85). By contrast, little is known regarding the
status of endogenous Cu at sites of infection.
Direct evidence thatCumay bemobilized to sites of infection
is provided by two recent studies. These detected an increased
Cu concentration in granulomatous lesions from guinea pigs
that were infected with M. tuberculosis when compared with
the uninfected control (13), and a significant accumulation of
Cu in urine of patients with urinary tract infection by uropatho-
genic E. coli when compared with urine from healthy subjects
(12). In retrospect, the latter is not altogether surprising. It is
well documented that Menkes patients are subject to recurring
urinary tract infections (86, 87). Menkes disease is a disorder of
Cu metabolism due to genetic defects in ATP7A, and clinical
manifestations of this disease often mimic Cu deficiency.
Gene expression analyses of bacteria that were isolated from
infected niches in the animal host have provided further sup-
port that Cu is trafficked to sites of infection. Expression of the
cop operon was up-regulated in S. pneumoniae isolated from
the murine nasopharynx (55). Expression of the secondary
Cu(I) efflux operon cusFCBA from uropathogenic E. coli was
induced in uropathogenic E. coli isolated from the urine of
infected mice (12). Consistently, a cusFCBAmutant strain was
attenuated in this animalmodel (12). An increase in the expres-
sion of copA was also detected (12), but the role of this gene in
the virulence of uropathogenicE. colihas not been established.4
Similarly, expression of ctpV from M. tuberculosis was highly
up-regulated in mice lungs. By contrast, there was little change
in mctB expression under the same conditions (88). This con-
tradicts results from phenotypic characterization, which found
only mctB and not ctpV to be essential for virulence (13, 64).
These findings indicate that gene expression patterns do not
always correlate with the importance of the gene in pathogen-
esis andmay point to a complex role for Cu that is yet to be fully
understood.
As described earlier, the main consideration with regard to
Zn at the host-pathogen interface has been the role of nutri-
tional immunity. In this context, the innate immune system
prevents Zn acquisition by a bacterial pathogen (2). In this pro-
cess, Zn is redistributed to various tissues such as the liver,
resulting in decreased serum Zn levels. This process can occur
through the IL-6-dependent up-regulation of ZIP14, the Zn
transporter responsible for accumulating Zn in hepatocytes
(89). Plasma Zn is also depleted, and themechanism appears to
involvemetallothionein, which is accumulated in the liver in its
Zn-bound form following stimulation by inflammatory cyto-
kines such as IL-1 (90).
Zn nutritional immunity is also exemplified by the action of
the human protein calprotectin, which sequesters Zn and Mn
and starves the bacterial pathogen of these trace metal nutri-
ents (91). Calprotectin is found abundantly in neutrophil extra-
cellular traps, which represent a key mode of extracellular bac-
tericidal killing by neutrophils (92). Here it needs to be noted
that calprotectin probably only exerts its effect once it is
released from the neutrophil (93, 94). Nevertheless, it may be
the case that there are specific niches where local elevation of
Zn is linked to its antimicrobial action. For example, it has been
shown that Zn is elevated in the nasopharynx upon a challenge
by S. pneumoniae (45). Thus, the antimicrobial action of the
elevated Zn may be associated with mucosal surfaces.
Conclusions
This review presents a now considerable body of data consis-
tent with the hypothesis that Cu and Zn toxicity can contribute
to the clearance of bacterial pathogens. This has led to the
intriguing concept of the “brass dagger” in innate immunity
(30), which then raises the question of how such a bactericidal
mechanism could be integrated into the complex immune sys-
tem of mammals. However, we suggest that the mechanisms
behind the antibacterial actions of Cu and Zn may be more
complicated than the simplistic view proposed by this model.
The systemic movements of Cu, Zn, and Fe in response to
bacterial infection are well documented. In the case of Zn, it is
clear that movement of this ion is central to the control of
inflammation and innate immune function. Trafficking of Zn to
intracellular locations may enhance the bactericidal capability
ofmacrophages and neutrophils. In such circumstances, robust
defenses against elevated Zn would be a requirement for a suc-
cessful intracellular bacterial pathogen. However, the question
of the bacterial niche still needs to be considered. Locally ele-
vated levels of Zn may well play a role in controlling growth of
extracellular mucosal pathogens, as already evidenced in the
case of S. pneumoniae in the nasopharynx (45).
The situation is more complex for Cu as increases in Cu
levels in the serum or at sites of infection are usually associated4 M. E. Achard and A. G. McEwan, unpublished results.
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with an increase in the production of ceruloplasmin (95, 96).
Ceruloplasmin is a ferroxidase and is a key component of Fe
homeostasis, but it is also amajor Cu store in cells as it binds six
Cu ions in the active site. Fe transport and regulation are linked
intimately with the inflammatory response, where removal
away from sites of infection is the norm. Based on our current
understanding of eukaryotic Fe homeostasis, movement of Fe
out of cells depends on the efflux of ferrous iron via ferroportin,
and this requires the ferroxidase activity of ceruloplasmin (97,
98). Assembly of holo-ceruloplasmin in the host endoplasmic
reticulum or Golgi relies on the transport of Cu via the Cu-
transporting ATP7B (99). As ATP7B is not found outside the
liver, in macrophages, this Cu transporter is presumed to be
ATP7A. Thus, although it is not surprising that engulfed patho-
gens encounter elevated Cu in macrophages, it is difficult to
separate a direct bactericidal effect of Cu ions from their key
role in facilitating the removal of Fe from the macrophage.
Whatever the relative importance of the two processes, it
does follow that possession of a Cu tolerance system would
enhance bacterial survival. In the case of some pathogens such
as S. pneumoniae, it appears that loss of copA is sufficient to
reduce survival within macrophages and in an animal model
(Table 1). However, professional intracellular pathogens such
as S. enterica and M. tuberculosis have more robust defenses
against Cu, and thus the loss of copA does not always have a
clear effect on their pathogenesis (Table 1). These inconsistent
phenotypes clearly illustrate the need to examine precisely
when, where, and how Cu exerts its effects on the innate
immune system. Central to future studies, at least in macro-
phages, is the requirement to directly determine whether Cu is
elevated in the same phagosomal compartment where the bac-
terial pathogen is located. The systematic cataloguing of viru-
lence phenotypes of Cu detoxificationmutants in various infec-
tion models and at various infection niches, even when there
are no clear effects, will also be increasingly important.
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